Ambu will be well positioned under potential Chinese ban on foreign medical equipment

The Danish medtech firm has production facilities in China, meaning it will avoid a potential ban on medical equipment not made in the country, which is being put in place by some hospitals on governmental request.

Photo: Ambu/PR

China is reportedly working on prohibiting the sales of medical equipment produced outside the country’s borders, leaving many global firms with a dilemma – leave the Chinese market, or let authorities gain insight into their technologies.

One product type entailed by the potential ban is endoscopes, reports Japanese media Nikkei. This would give Danish firm Ambu an advantage, as the company has production in China, a representative tells MarketWire:

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs